[January 20, 2010 VIA EDGAR AND OVERNIGHT COURIER Division of Corporation Finance 100 F Street, NE Attn: Norman Gholson Attorney-Advisor Re: Synutra International, Inc. Form 10-K for the Fiscal Year Ended March 31, 2009 Filed June 15, 2009 Form 10-Q for the Fiscal Quarter Ended June 30, 2009 Filed August 10, 2009 File No. 001-33397 Ladies and Gentlemen: We respectfully]
[January 20, 2010 VIA EDGAR AND OVERNIGHT COURIER Division of Corporation Finance 100 F Street, NE Attn: Norman Gholson Attorney-Advisor Re: Synutra International, Inc. Registration Statement on Form S-3 Filed December 11, 2009 File No. 333-163677 Ladies and Gentlemen: General 1. 2. We note that there are unresolved, outstanding staff comments on your Form 10-K for the fiscal year ended]
[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be Proposedmaximum Proposedmaximum Amountof Ordinary Shares, par value $0.0001 per share (3) 44,850,000 $2.42 $108,387,500 $7,728.03 STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4) (1) Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(a) under the Securities] [KADDEN RPS LATE EAGHER LOM S 300 SOUTH GRAND AVENUE STYLE="font-family:Times New Roman" SIZE="2">LOS ANGELES,LIFORNIA 90071-3144 __________ TEL: (213) 687-5000 FAX: (213) 687-5600 SIZE="2">www.skadden.com FIRM/AFFILIATE OFFICES __________ BOSTON CHICAGO SIZE="2">HOUSTON NEW YORK STYLE="font-family:Times New Roman" SIZE="2">PALOTONFRANCISCO WASHINGTON,D.C. WILMINGTON __________ BEIJING SIZE="2">BRUSSELS FRANKFURT STYLE="font-family:Times New Roman" SIZE="2">HONG KONG] [UN E AW FFICES J China Resources Building, 20th Floor Beijing 100005, P. R. China SIZE="2">Tel.: (86-10) 8519-1300 Fax: (86-10) 8519-1350 E-mail: junhebj@junhe.com Homepage: www.junhe.com To:qo New Energyrp. Dear Sirs, We are lawyers qualified in the Peoples Republic of China (thempany Registration Statement SEC ProspectusSs STYLE="font-family:Times New Roman" SIZE="2">We are acting theunsel toqo New Energyrp.] [STYLE="font-family:Times New Roman" SIZE="2"> Loanntract (in RMB) Chinanstruction Bank SIZE="2"> Chongqing Branch 2008 (1270) 5ntract No.:pitalnstruction loan STYLE="font-family:Times New Roman" SIZE="2">Type of Loan:qo New Materials The Borrower (Party A): Wanzhou Industry Park, Chongqing, China Domicile: 404000 Postde: Xu Guangfu Legal representative (principal):] [STYLE="font-family:Times New Roman" SIZE="2"> Loanntract (in RMB) Chinanstruction Bank SIZE="2"> Chongqing Branch 2008 (1270) 19ntract No.:pitalnstruction loan STYLE="font-family:Times New Roman" SIZE="2">Type of Loan:qo New Materials The Borrower (Party A): Wanzhou Industry Park, Chongqing, China Domicile: 404000 Postde: Xu Guangfu Legal representative (principal):] [STYLE="font-family:Times New Roman" SIZE="2"> Reference No: CBC Syndicate Medium-to-long Term (2009)08 August28, 2009 STYLE="font-family:Times New Roman" SIZE="2">Chongqingqo New Energy the Borrower Chinanstruction Bank, Chongqing Branch STYLE="font-family:Times New Roman" SIZE="2">As the Lead Manager Chinanstruction Bank, Wanzhou Branch theent Bank SIZE="2">and Chinanstruction Bank, Wanzhou Branch] [STYLE="font-family:Times New Roman" SIZE="2"> Supplementalreement to the Medium-to-Long Term Syndicated Loanreement STYLE="font-family:Times New Roman" SIZE="2">This Supplementalreement is entered into of December10, 2009 by and among: SIZE="2">(1) Chongqingqo New Energy Sources ampany duly organized and existing under the laws of the Peoples Republic of China with its registereddress at XianJia Village, Longdu Neighborhood, Wanzhou District, Chongqing,] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Shanghai, China January 20, 2010NSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Shanghai, China January 20, 2010NSENT OF DELOITTE TOUCHE TOHMATSU CPA dex231.htm 8 EX-23.1]
[Sinovac Biotech Ltd. 8,650,000 Common Shares We are offering 8,650,000 common shares through this prospectus supplement and the accompanying prospectus. Our common shares are listed on the NASDAQ Global Market under the symbol "SVA." The last reported sale price of our common shares on January 19, 2010 was $7.49 per share. Investing in our common shares involves a high degree]
[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be Proposedmaximum Proposedmaximum Amountof Ordinary Shares, par value $0.0001 per share (3) 44,850,000 $2.42 $108,387,500 $7,728.03 STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4) (1) Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(a) under the Securities] [KADDEN RPS LATE EAGHER LOM S 300 SOUTH GRAND AVENUE STYLE="font-family:Times New Roman" SIZE="2">LOS ANGELES,LIFORNIA 90071-3144 __________ TEL: (213) 687-5000 FAX: (213) 687-5600 SIZE="2">www.skadden.com FIRM/AFFILIATE OFFICES __________ BOSTON CHICAGO SIZE="2">HOUSTON NEW YORK STYLE="font-family:Times New Roman" SIZE="2">PALOTONFRANCISCO WASHINGTON,D.C. WILMINGTON __________ BEIJING SIZE="2">BRUSSELS FRANKFURT STYLE="font-family:Times New Roman" SIZE="2">HONG KONG] [UN E AW FFICES J China Resources Building, 20th Floor Beijing 100005, P. R. China SIZE="2">Tel.: (86-10) 8519-1300 Fax: (86-10) 8519-1350 E-mail: junhebj@junhe.com Homepage: www.junhe.com To:qo New Energyrp. Dear Sirs, We are lawyers qualified in the Peoples Republic of China (thempany Registration Statement SEC ProspectusSs STYLE="font-family:Times New Roman" SIZE="2">We are acting theunsel toqo New Energyrp.] [STYLE="font-family:Times New Roman" SIZE="2"> Loanntract (in RMB) Chinanstruction Bank SIZE="2"> Chongqing Branch 2008 (1270) 5ntract No.:pitalnstruction loan STYLE="font-family:Times New Roman" SIZE="2">Type of Loan:qo New Materials The Borrower (Party A): Wanzhou Industry Park, Chongqing, China Domicile: 404000 Postde: Xu Guangfu Legal representative (principal):] [STYLE="font-family:Times New Roman" SIZE="2"> Loanntract (in RMB) Chinanstruction Bank SIZE="2"> Chongqing Branch 2008 (1270) 19ntract No.:pitalnstruction loan STYLE="font-family:Times New Roman" SIZE="2">Type of Loan:qo New Materials The Borrower (Party A): Wanzhou Industry Park, Chongqing, China Domicile: 404000 Postde: Xu Guangfu Legal representative (principal):] [STYLE="font-family:Times New Roman" SIZE="2"> Reference No: CBC Syndicate Medium-to-long Term (2009)08 August28, 2009 STYLE="font-family:Times New Roman" SIZE="2">Chongqingqo New Energy the Borrower Chinanstruction Bank, Chongqing Branch STYLE="font-family:Times New Roman" SIZE="2">As the Lead Manager Chinanstruction Bank, Wanzhou Branch theent Bank SIZE="2">and Chinanstruction Bank, Wanzhou Branch] [STYLE="font-family:Times New Roman" SIZE="2"> Supplementalreement to the Medium-to-Long Term Syndicated Loanreement STYLE="font-family:Times New Roman" SIZE="2">This Supplementalreement is entered into of December10, 2009 by and among: SIZE="2">(1) Chongqingqo New Energy Sources ampany duly organized and existing under the laws of the Peoples Republic of China with its registereddress at XianJia Village, Longdu Neighborhood, Wanzhou District, Chongqing,] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Shanghai, China January 20, 2010NSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Shanghai, China January 20, 2010NSENT OF DELOITTE TOUCHE TOHMATSU CPA dex231.htm 8 EX-23.1]
[Equity Joint Venture Contract for the establishment of Sinovac (Dalian) Vaccine Technology Co., Ltd. i Table of Contents Chapter I The Parties 1 Chapter II Establishment of Joint Venture 1 Chapter III Purpose, Business Scope and Size 2 Chapter IV Aggregate Investment and Registered Capital 2 Chapter V Contribution Proportion and Deadline of the Parties 2 Chapter VI Responsibilities of] [MEMORANDUM This Memorandum is made on 22 November 2009: BETWEEN: 1. Dalian Jingang Group Co., Ltd. , with its legal address at No. 59, Liaohe Middle Road, Dalian 2. Sinovac Biotech (Hong Kong) Ltd. , a limited liability company duly incorporated and validly existing under the laws of the Hong Kong Special Administrative Region, the Peoples Republic of China (hereinafter] [EQUITY INTEREST TRANSFER AGREEMENT BY AND BETWEEN DALIAN JINGANG GROUP CO., LTD. AND SINOVAC (HONG KONG) BIOTECH LTD. IN RESPECT OF 25% EQUITY INTEREST OF December 17, 2009 This Agreement is made on BETWEEN: 1. Dalian Jingang Group Co., Ltd., a limited liability company organized and existing under the laws of the Peoples Republic of China (hereinafter referred to as] [Sinovac Announces Recent Developments BEIJING, January 20, 2010 Sinovac Biotech Ltd. (NASDAQ: SVA) (Sinovac or the Company), a leading China-based vaccine manufacturer, today announced the following recent developments. Dalian Joint Venture Acquisition of Buildings and Land Sinovac is in advanced negotiations for the acquisition of buildings, land use rights and utility facilities for a total consideration of approximately RMB120] [01 - 32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o Incorporation by Reference 2]
[Equity Joint Venture Contract for the establishment of Sinovac (Dalian) Vaccine Technology Co., Ltd. i Table of Contents Chapter I The Parties 1 Chapter II Establishment of Joint Venture 1 Chapter III Purpose, Business Scope and Size 2 Chapter IV Aggregate Investment and Registered Capital 2 Chapter V Contribution Proportion and Deadline of the Parties 2 Chapter VI Responsibilities of] [MEMORANDUM This Memorandum is made on 22 November 2009: BETWEEN: 1. Dalian Jingang Group Co., Ltd. , with its legal address at No. 59, Liaohe Middle Road, Dalian 2. Sinovac Biotech (Hong Kong) Ltd. , a limited liability company duly incorporated and validly existing under the laws of the Hong Kong Special Administrative Region, the Peoples Republic of China (hereinafter] [EQUITY INTEREST TRANSFER AGREEMENT BY AND BETWEEN DALIAN JINGANG GROUP CO., LTD. AND SINOVAC (HONG KONG) BIOTECH LTD. IN RESPECT OF 25% EQUITY INTEREST OF December 17, 2009 This Agreement is made on BETWEEN: 1. Dalian Jingang Group Co., Ltd., a limited liability company organized and existing under the laws of the Peoples Republic of China (hereinafter referred to as] [Sinovac Announces Recent Developments BEIJING, January 20, 2010 Sinovac Biotech Ltd. (NASDAQ: SVA) (Sinovac or the Company), a leading China-based vaccine manufacturer, today announced the following recent developments. Dalian Joint Venture Acquisition of Buildings and Land Sinovac is in advanced negotiations for the acquisition of buildings, land use rights and utility facilities for a total consideration of approximately RMB120] [01 - 32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o Incorporation by Reference 2]
